PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion

X. Liu, Y. Hu, Chunhai Hao, S. A. Rempel, K. Ye

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

PIKE-A (phosphoinositide 3-kinases (PI 3)-kinase enhancer) is a ubiquitously expressed GTPase, which binds to and enhances protein kinase B (Akt) kinase activity in a guanine nucleotide-dependent manner. PIKE-A is one of the components of the CDK4 amplicon that is amplified in numerous human cancers. However, whether PIKE-A itself can mediate cell transformation, proliferation and migration remains unknown. Here, we show that PIKE-A is overexpressed in various human cancer samples, escalates U87MG glioblastoma invasion and provokes NIH3T3 cell transformation. Overexpression of wild-type (WT) PIKE-A enhances NIH3T3 and U87MG cell growth, which is further increased by cancer cell-derived PIKE-A active mutants. In contrast, both the dominant-negative mutant and the phosphoinositide lipids interaction-defective mutant antagonize cell proliferation. Moreover, PIKE-A and its active and inactive mutants similarly enhance or antagonize U87MG cell survival and invasion, and their ability to do so is coupled with the catalytic effect they have on Akt activation. Furthermore, PIKE-A WT and its active mutants significantly elicit NIH3T3 cell transformation. Thus, our findings support the concept that PIKE-A acts as a proto-oncogene, promoting cell transformation through Akt activation.

Original languageEnglish (US)
Pages (from-to)4918-4927
Number of pages10
JournalOncogene
Volume26
Issue number34
DOIs
StatePublished - Jul 26 2007
Externally publishedYes

Fingerprint

1-Phosphatidylinositol 4-Kinase
Proto-Oncogenes
Phosphatidylinositol 3-Kinases
Growth
Phosphotransferases
Cell Proliferation
Neoplasms
Proto-Oncogene Proteins c-akt
Guanine Nucleotides
GTP Phosphohydrolases
Glioblastoma
Phosphatidylinositols
Cell Movement
Cell Survival
Lipids

Keywords

  • Akt
  • Cell invasion
  • PIKE-A
  • Proto-oncogene
  • Transformation

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion. / Liu, X.; Hu, Y.; Hao, Chunhai; Rempel, S. A.; Ye, K.

In: Oncogene, Vol. 26, No. 34, 26.07.2007, p. 4918-4927.

Research output: Contribution to journalArticle

Liu, X. ; Hu, Y. ; Hao, Chunhai ; Rempel, S. A. ; Ye, K. / PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion. In: Oncogene. 2007 ; Vol. 26, No. 34. pp. 4918-4927.
@article{72d69cce57324c3e9757b82e0b4bbff4,
title = "PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion",
abstract = "PIKE-A (phosphoinositide 3-kinases (PI 3)-kinase enhancer) is a ubiquitously expressed GTPase, which binds to and enhances protein kinase B (Akt) kinase activity in a guanine nucleotide-dependent manner. PIKE-A is one of the components of the CDK4 amplicon that is amplified in numerous human cancers. However, whether PIKE-A itself can mediate cell transformation, proliferation and migration remains unknown. Here, we show that PIKE-A is overexpressed in various human cancer samples, escalates U87MG glioblastoma invasion and provokes NIH3T3 cell transformation. Overexpression of wild-type (WT) PIKE-A enhances NIH3T3 and U87MG cell growth, which is further increased by cancer cell-derived PIKE-A active mutants. In contrast, both the dominant-negative mutant and the phosphoinositide lipids interaction-defective mutant antagonize cell proliferation. Moreover, PIKE-A and its active and inactive mutants similarly enhance or antagonize U87MG cell survival and invasion, and their ability to do so is coupled with the catalytic effect they have on Akt activation. Furthermore, PIKE-A WT and its active mutants significantly elicit NIH3T3 cell transformation. Thus, our findings support the concept that PIKE-A acts as a proto-oncogene, promoting cell transformation through Akt activation.",
keywords = "Akt, Cell invasion, PIKE-A, Proto-oncogene, Transformation",
author = "X. Liu and Y. Hu and Chunhai Hao and Rempel, {S. A.} and K. Ye",
year = "2007",
month = "7",
day = "26",
doi = "10.1038/sj.onc.1210290",
language = "English (US)",
volume = "26",
pages = "4918--4927",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "34",

}

TY - JOUR

T1 - PIKE-A is a proto-oncogene promoting cell growth, transformation and invasion

AU - Liu, X.

AU - Hu, Y.

AU - Hao, Chunhai

AU - Rempel, S. A.

AU - Ye, K.

PY - 2007/7/26

Y1 - 2007/7/26

N2 - PIKE-A (phosphoinositide 3-kinases (PI 3)-kinase enhancer) is a ubiquitously expressed GTPase, which binds to and enhances protein kinase B (Akt) kinase activity in a guanine nucleotide-dependent manner. PIKE-A is one of the components of the CDK4 amplicon that is amplified in numerous human cancers. However, whether PIKE-A itself can mediate cell transformation, proliferation and migration remains unknown. Here, we show that PIKE-A is overexpressed in various human cancer samples, escalates U87MG glioblastoma invasion and provokes NIH3T3 cell transformation. Overexpression of wild-type (WT) PIKE-A enhances NIH3T3 and U87MG cell growth, which is further increased by cancer cell-derived PIKE-A active mutants. In contrast, both the dominant-negative mutant and the phosphoinositide lipids interaction-defective mutant antagonize cell proliferation. Moreover, PIKE-A and its active and inactive mutants similarly enhance or antagonize U87MG cell survival and invasion, and their ability to do so is coupled with the catalytic effect they have on Akt activation. Furthermore, PIKE-A WT and its active mutants significantly elicit NIH3T3 cell transformation. Thus, our findings support the concept that PIKE-A acts as a proto-oncogene, promoting cell transformation through Akt activation.

AB - PIKE-A (phosphoinositide 3-kinases (PI 3)-kinase enhancer) is a ubiquitously expressed GTPase, which binds to and enhances protein kinase B (Akt) kinase activity in a guanine nucleotide-dependent manner. PIKE-A is one of the components of the CDK4 amplicon that is amplified in numerous human cancers. However, whether PIKE-A itself can mediate cell transformation, proliferation and migration remains unknown. Here, we show that PIKE-A is overexpressed in various human cancer samples, escalates U87MG glioblastoma invasion and provokes NIH3T3 cell transformation. Overexpression of wild-type (WT) PIKE-A enhances NIH3T3 and U87MG cell growth, which is further increased by cancer cell-derived PIKE-A active mutants. In contrast, both the dominant-negative mutant and the phosphoinositide lipids interaction-defective mutant antagonize cell proliferation. Moreover, PIKE-A and its active and inactive mutants similarly enhance or antagonize U87MG cell survival and invasion, and their ability to do so is coupled with the catalytic effect they have on Akt activation. Furthermore, PIKE-A WT and its active mutants significantly elicit NIH3T3 cell transformation. Thus, our findings support the concept that PIKE-A acts as a proto-oncogene, promoting cell transformation through Akt activation.

KW - Akt

KW - Cell invasion

KW - PIKE-A

KW - Proto-oncogene

KW - Transformation

UR - http://www.scopus.com/inward/record.url?scp=33947322795&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947322795&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1210290

DO - 10.1038/sj.onc.1210290

M3 - Article

VL - 26

SP - 4918

EP - 4927

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 34

ER -